Interaction Checker

Interacciones de Lanreotida

Lanreotida (Somatuline Depot) tiene 68 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 2; moderadas: 66; leves: 0; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 0. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Interacciones según la etiqueta

Interacciones graves (2)

  • Dextrometorfano y quinidinafármaco serotoninérgicoGrave

    Since it cannot be excluded that Lanreotide Injection may have this effect, avoid other drugs mainly metabolized by CYP3A4 and which have a low therapeutic index (e.g., quinidine, terfenadine). (etiqueta de Lanreotida, Interacciones medicamentosas)

  • QuinidinaantiarrítmicoGrave

    Since it cannot be excluded that Lanreotide Injection may have this effect, avoid other drugs mainly metabolized by CYP3A4 and which have a low therapeutic index (e.g., quinidine, terfenadine). (etiqueta de Lanreotida, Interacciones medicamentosas)

Interacciones moderadas (66)

  • AcarbosaantidiabéticoModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • AcebutololbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Alogliptinainhibidor de la DPP-4Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Alogliptina y metforminainhibidor de la DPP-4Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • AtenololbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Atenolol y clortalidonabetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • BetaxololbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Bexagliflozinainhibidor de SGLT2Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • BisoprololbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Bisoprolol e hidroclorotiazidabetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Brimonidina y timololagonista alfa-adrenérgicoModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Bromocriptinaagonista de la dopaminaModerada

    Bromocriptine : Lanreotide Injection may increase the absorption of bromocriptine. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Canagliflozinainhibidor de SGLT2Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • CarvedilolbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • CiclosporinainmunosupresorModerada

    Cyclosporine : Lanreotide Injection may decrease the absorption of cyclosporine. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Dapagliflozinainhibidor de SGLT2Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Dapagliflozina y metforminainhibidor de SGLT2Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Dorzolamida y timololinhibidor de la anhidrasa carbónicaModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Dulaglutidaagonista del receptor de GLP-1Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Empagliflozinainhibidor de SGLT2Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Empagliflozina y metforminainhibidor de SGLT2Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • EsmololbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Exenatidaagonista del receptor de GLP-1Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • GlibenclamidasulfonilureaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Glibenclamida y metforminasulfonilureaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • GlimepiridasulfonilureaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • GlipizidasulfonilureaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Glipizida y metforminasulfonilureaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • GlucagónModerada

    Hyperglycemia and Hypoglycemia Pharmacological studies in animals and humans show that lanreotide, like somatostatin and other somatostatin analogs, inhibits the secretion of insulin and glucagon. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Insulina aspartainsulinaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Insulina degludecinsulinaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Insulina detemirinsulinaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Insulina glarginainsulinaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Insulina lisproinsulinaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Insulina regular (humana)insulinaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • LabetalolbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Levotiroxinahormona tiroideaModerada

    Thyroid Function Abnormalities : Decreases in thyroid function may occur; perform tests where clinically indicated. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Levotiroxina y liotironinahormona tiroideaModerada

    Thyroid Function Abnormalities : Decreases in thyroid function may occur; perform tests where clinically indicated. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Linagliptinainhibidor de la DPP-4Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Linagliptina y metforminainhibidor de la DPP-4Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Liotironinahormona tiroideaModerada

    Thyroid Function Abnormalities : Decreases in thyroid function may occur; perform tests where clinically indicated. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Liraglutidaagonista del receptor de GLP-1Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • MetforminabiguanidaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Metimazolfármaco antitiroideoModerada

    Thyroid Function Abnormalities : Decreases in thyroid function may occur; perform tests where clinically indicated. (etiqueta de Lanreotida, Advertencias y precauciones)

  • MetoprololbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Metoprolol e hidroclorotiazidabetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • MiglitolantidiabéticoModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • NadololbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • NateglinidameglitinidaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • NebivololbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • PindololbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • PioglitazonatiazolidinedionaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Pioglitazona y glimepiridatiazolidinedionaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Pioglitazona y metforminatiazolidinedionaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Propiltiouracilofármaco antitiroideoModerada

    Thyroid Function Abnormalities : Decreases in thyroid function may occur; perform tests where clinically indicated. (etiqueta de Lanreotida, Advertencias y precauciones)

  • PropranololbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • RepaglinidameglitinidaModerada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Saxagliptinainhibidor de la DPP-4Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Saxagliptina y metforminainhibidor de la DPP-4Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Semaglutidaagonista del receptor de GLP-1Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Sitagliptinainhibidor de la DPP-4Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • Sitagliptina y metforminainhibidor de la DPP-4Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

  • SotalolbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Teriparatidahormona tiroideaModerada

    Thyroid Function Abnormalities : Decreases in thyroid function may occur; perform tests where clinically indicated. (etiqueta de Lanreotida, Advertencias y precauciones)

  • TimololbetabloqueanteModerada

    Bradycardia-Inducing Drugs (e.g., beta-blockers) : Lanreotide Injection may decrease heart rate. (etiqueta de Lanreotida, Interacciones medicamentosas)

  • Tirzepatidaagonista del receptor de GLP-1Moderada

    Hyperglycemia and Hypoglycemia : Glucose monitoring is recommended and antidiabetic treatment adjusted accordingly. (etiqueta de Lanreotida, Advertencias y precauciones)

Compruebe Lanreotida frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.